The final results of Sweco’s rights issue show that 1,165,545 A-shares and 12,044,308 B-shares, representing approximately 99.4 percent of the offered shares, were subscribed for with subscription rights. The remaining 5,475 A -shares and 79,617 B-shares that were not subscribed for with subscription rights have been allocated to persons who have applied for subscription of shares not subscribed for with subscription rights according to the principles described in the prospectus. Allotment of shares not subscribed for with subscription rights has only been made to those who have subscribed for shares with subsidiary preferential right. Through the rights issue, Sweco will receive proceeds amounting to approximately SEK 1,077 million before issue costs.[1] (http://file:///P:/9020/PR/Pressmeddelanden/Engelska_versioner/2015/pr m _emission%20slutligt%20resultat%20151203%20ENG.docx#_ftn1) Notification regarding allocation of shares that have been subscribed for without subscription rights has been distributed to those who have been allocated shares for payment on 4 December 2015. Only those who are allotted shares have been notified. As a result of the rights issue, Sweco’s share capital increases by SEK 13,294,945, from SEK 107,799,885 to SEK 121,094,830. The number of A-shares in Sweco will increase by 1,171,020 to 10,539,184 A-shares and the number of B -shares will increase by 12,123,925 to 109,655,646 B-shares. The total number of shares in Sweco will thus amount to 121,094,830, whereof 10,539,184 A-shares, 109,655,646 B-shares and 900,000 C-shares. The new shares subscribed for with subscription rights have been registered at the Swedish Companies Registration Office on 2 December 2015. The final day for trading in paid subscribed shares (BTAs) is expected to be on 7 December 2015. The new shares are expected to start trading on Nasdaq Stockholm on 11 December 2015. Shares subscribed for without subscription rights are expected to be registered at the Swedish Companies Registration Office on or around 9 December 2015 and to start trading on Nasdaq Stockholm on 22 December 2015. ABN AMRO Bank N.V. and Nordea Bank AB (publ) are financial advisors and Cederquist is legal advisor to Sweco in the Rights Issue. Important notice This press release does not contain or constitute an invitation or an offer to acquire, sell, subscribe for or otherwise trade in shares, subscription rights or other securities in Sweco. Invitation to the persons concerned to subscribe for shares in Sweco is only made through the prospectus that has been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen), and is available on Sweco's website. The prospectus contains, among other things, pro forma financial statements as well as information regarding the new Sweco group (inclusive of information regarding Grontmij) and Sweco's Board. This press release has not been approved by any regulatory authority and is not a prospectus, accordingly investors should not subscribe for or purchase any securities referred to in this press release except on the basis of information provided in the prospectus published by Sweco. In certain jurisdictions, the publication or distribution of this press release may be subject to restrictions according to law and persons in those jurisdictions where this press release has been published or distributed should inform themselves about and abide by such restrictions. This press release is not directed at persons located in the United States (including its territories and possessions, any state of the United States and the District of Columbia) (the "United States"), Canada, Australia, Hong Kong, Japan, New Zealand or in any other country where the offer or sale of the subscription rights, paid subscribed shares (Sw. betalda tecknade aktier "BTA") or new shares is not permitted. This press release may not be announced, published or distributed, directly or indirectly, in or into the United States, Australia, Canada, Hong Kong, Japan, New Zealand or any other country where such action is wholly or partially subject to legal restrictions or where such action would require additional prospectuses, other offer documentation, registrations or other actions in addition to what follows from Swedish law. Nor may the information in this press release be forwarded, reproduced or disclosed in such a manner that contravenes such restrictions or would require such additional prospectuses, other offer documentation, registrations or other actions. Failure to comply with this instruction may result in a violation of the United States Securities Act of 1933, as amended (the "Securities Act") or laws applicable in other jurisdictions. In addition, if and to the extent that this press release is communicated in any European Economic Area member state that has implemented Directive 2003/71/EC (together with any applicable implementing measures, including Directive 2010/73/EC, in any member state, the "Prospectus Directive"), this press release is only addressed to and directed at persons in Sweden and the member states that the prospectus has been passported to (Finland, the Netherlands and Norway) and persons in other members state who are "qualified investors" within the meaning of the Prospectus Directive and must not be acted on or relied on by other persons in that member state. This press release does not constitute a prospectus within the meaning of the Prospectus Directive or an offer to the public. In the United Kingdom, this press release is being distributed only to, and is directed only at (i) persons who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Financial Promotion Order"), (ii) persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Promotion Order, or (iii) other persons to whom it may otherwise be lawfully communicated (all such persons together being referred to as "relevant persons"). This press release is directed only at relevant persons and must not be acted on or relied on by anyone who is not a relevant person. No subscription rights, paid subscribed shares (BTAs) or new shares have been or will be registered under the Securities Act, or with any other securities regulatory authority of any state or other jurisdiction of the United States and no subscription rights, paid subscribed shares (BTAs) or new shares may be offered, sold, resold, transferred, delivered or distributed, directly or indirectly, into or within the United States other than pursuant to an exemption from, or in a transaction not subject to the registration requirements of the Securities Act, and in compliance with any applicable securities laws of any state or jurisdiction of the United States. There is no intention to register any securities referred to herein in the United States or to make a public offering of the securities in the United States ---------------------------------------------------------------------- [1] (http://file:///P:/9020/PR/Pressmeddelanden/Engelska_versioner/2015/prm_emis s ion%20slutligt%20resultat%20151203%20ENG.docx#_ftnref1) From the proceeds of the rights issue of approximately SEK 1,077 million, an estimated deduction is made for rights issue expenses (issue costs). These costs are estimated to approximately SEK 20 million. Net of issuance costs Sweco is estimated to raise approximately SEK 1,057 million. The issue proceeds of approximately SEK 1,077 million is based on the total number of Sweco A shares and Sweco B shares excluding Sweco’s own holding of 540,320 Sweco B shares. For further information please contact: Lisa Lagerwall, General Counsel, +46 (0)8-695 66 16, lisa.lagerwall@sweco.se Åsa Barsness, Communications Director, +46 (0)8-695 66 40, asa.barsness@sweco.se Sweco plans and designs the communities and cities of the future. Our work results in sustainable buildings, efficient infrastructure and access to electricity and clean water. With 14,500 employees in Europe, we offer our customers the right expertise for every situation. We carry out projects in 70 countries annually throughout the world. Sweco is the leading architecture and engineering consultancy in Europe, with sales of approximately SEK 15.2 billion (pro forma 2014). The company is listed on NASDAQ Stockholm. The information contained herein is subject to the disclosure requirements of Sweco AB under the Swedish Securities Exchange and Clearing Operations Act and/or the Financial Instruments Trading Act. The information was submitted for publication on 3 December 2015, 8:30 a.m. CET.
Final results of Sweco’s rights issue The final results
Top 10 Most Recent News Articles
ASTS Faces Class Action; Investors Beware of Pitfalls
Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...
Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts
NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...
Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms
A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...
Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity
Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...
Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future
MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...
Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer
Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...
Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels
Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...
Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction
Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...
Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift
China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...
Continue Reading
Novo's Semaglutide Shows Promise in MASH Study
Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...
Continue ReadingTop 5 Most Recently Viewed Articles
Marina Genova Joins SEA Index to Promote Sustainable Yachting
Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....
Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know
Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...
Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies
Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...
Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution
So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...
Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70
JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....
Continue Reading